AKR1C4

AKR1C4

Target · Steroid-metabolising enzyme

AKR1C4 Aldo-keto reductase family 1 member C4 · 3-alpha-hydroxysteroid dehydrogenase, type I

AKR1C4 (aldo-keto reductase family 1 member C4, also known as DD4, HAKRA, C11, 3-alpha-HSD, CDR and CHDR) is a cytosolic NADPH-dependent reductase that converts ketosteroids to hydroxysteroids. It also biotransforms the organochlorine pesticide chlordecone. Browse Assay Genie's current range of AKR1C4 research reagents below, or read on for the biology behind the target.

Cytosolic enzymeKetosteroid reductaseChlordecone biotransformation
323 aa
Protein length
~37 kDa
Molecular weight
10p15.1
Gene locus
EC 1.1.1.-
Enzyme class
Target information

What is AKR1C4 (aldo-keto reductase family 1 member C4)?

AKR1C4 is a cytosolic aldo-keto reductase that catalyses the NADPH-dependent reduction of ketosteroids to hydroxysteroids. It shows broad substrate specificity with distinct positional and stereochemical preferences, primarily generating 3alpha/beta-, 17beta- and 20alpha-hydroxysteroids. By altering which steroids are active, it regulates ligand availability for steroid hormone receptors. It inactivates 5alpha-dihydrotestosterone and progesterone, converting them into 3alpha/beta-androstanediols and (20S)-hydroxypregn-4-en-3-one respectively, and reduces estrone to 17beta-estradiol, although with low efficiency.

The enzyme is required for male sex determination as part of the 'backdoor' androgen biosynthesis pathway that generates 5alpha-dihydrotestosterone via pregnanes. Together with AKR1C2, it converts 5alpha-dihydroprogesterone to allopregnanolone, leading to the 5alpha-DHT secretion needed for embryonic gonad differentiation into testis. It also reduces 5alpha-dihydroprogesterone and 5alpha-dihydrodeoxycorticosterone to neuroactive steroids that alter neural excitability through allosteric activation of GABAA receptors, and so may regulate circulating neurosteroid concentrations. It may contribute to the metabolism of adrenal-derived androgens, and in androgen catabolism it acts mainly as a phase I enzyme, although it can also reduce sulfate- or glucuronide-conjugated androgens directly.

The AKR1C4 gene encodes a member of the aldo/keto reductase superfamily, enzymes that convert aldehydes and ketones to alcohols using NADH and/or NADPH. In liver, AKR1C4 catalyses the bioreduction of the toxic pesticide chlordecone (kepone) to chlordecone alcohol, which increases biliary excretion and reduces neurotoxicity. This activity gave rise to the earlier name chlordecone reductase. In vitro the enzyme can run in both directions with NADPH/NADP+ or NADH/NAD+, but in vivo reductase activity prevails because NADPH inhibits NAD+-dependent oxidation. The gene shares high sequence identity with three other family members and is clustered with them on chromosome 10.

Steroid hormone metabolism

AKR1C4 reduces ketosteroids to hydroxysteroids and regulates ligand availability for steroid hormone receptors, making it relevant to androgen and progestogen inactivation.

Sex determination and development

As part of the backdoor androgen pathway with AKR1C2, AKR1C4 supports 5alpha-DHT production needed for embryonic gonad differentiation into testis.

Neurosteroid signalling

AKR1C4 generates allopregnanolone and related neuroactive steroids that modulate GABAA receptor activity and neural excitability.

Xenobiotic detoxification

AKR1C4 converts chlordecone to its alcohol in liver, increasing biliary excretion and lowering neurotoxicity of this organochlorine pesticide.

Background

AKR1C4 frequently asked questions

What does AKR1C4 do?

AKR1C4 is a cytosolic aldo-keto reductase that uses NADPH to reduce ketosteroids to hydroxysteroids. It takes part in androgen biosynthesis and inactivation, may regulate neurosteroid levels, and converts the pesticide chlordecone to chlordecone alcohol in liver, which promotes its biliary excretion.

What other names is AKR1C4 known by?

AKR1C4 is also called DD4, HAKRA, C11, 3-alpha-HSD, CDR and CHDR. Earlier names include chlordecone reductase, 3-alpha hydroxysteroid dehydrogenase type I and dihydrodiol dehydrogenase 4. These reflect its steroid and xenobiotic substrates. The HGNC group is aldo-keto reductases.

How is AKR1C4 related to other aldo-keto reductases?

AKR1C4 belongs to the aldo/keto reductase superfamily and shares high sequence identity with three other genes clustered with it on chromosome 10p15-p14. It acts with AKR1C2 in the backdoor androgen pathway. Substrate specificities among family members overlap but remain distinct.

Explore

Related targets

Other aldo-keto reductases, including the AKR1C subfamily members that share sequence identity and steroid-metabolising roles with AKR1C4.

Gene and protein annotations from HGNC, NCBI Gene and UniProt P17516; product specifications from Assay Genie datasheets.

AKR1C4 Product listing